ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS · Delayed Price · Currency is USD
0.2600
-0.0025 (-0.95%)
At close: Feb 27, 2026
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $2.1 million as of February 27, 2026. Its market cap has decreased by -35.94% in one year.
Market Cap
2.10M
Enterprise Value
1.58M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.26
Market Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from 95.47M to 2.10M, a decrease of -97.80%. That is a compound annual growth rate of -61.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 2.10M | 94.61% |
| Dec 31, 2025 | 1.08M | -59.32% |
| Dec 31, 2024 | 2.66M | -43.66% |
| Dec 29, 2023 | 4.72M | -66.90% |
| Dec 30, 2022 | 14.26M | -85.07% |
| Feb 10, 2022 | 95.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orgenesis | 2.95M |
| ProtoKinetix | 2.77M |
| Vaccinex | 2.76M |
| Clearside Biomedical | 2.67M |
| LakeShore Biopharma | 2.65M |
| Enzolytics | 2.42M |
| VitaSpring Biomedical | 2.30M |
| Agentix | 2.00M |